Low-frequency TMS ameliorates neonatal hypoxia-ischemia injury by normalizing glutamatergic transmission in penumbra.

Providing evidence-based psychiatric care and advanced TMS therapy for adults experiencing depression, anxiety, and treatment-resistant mood disorders.